Patient-derived neurospheres are grown in enriched EGF/bFGF media under low attachment conditions; when these factors are replaced by serum, glioma CSCs phenotypically change their appearance, loosen cellular adhesions, and turn the neurosphere into a 2D cell culture with decreasing CSC marker expression and telomerase activity (Lee et al., 2006; Claes et al., 2008). The gene discussed is FGF2; the disease is central nervous system cancer.